Maryam Mohammadi

Maryam Mohammadi

Auto-generated profile, based on publicly available information

Maryam Mohammadi

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2017 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
MMMaryam Mohammadi
Maryam Mohammadi
APAkram Pezeshki
Akram Pezeshki
MAMehran Mesgari Abbasi
Mehran Mesgari Abbasi
BGBabak Ghanbarzadeh
Babak Ghanbarzadeh
HHHamed Hamishehkar
Hamed Hamishehkar
Vitamin D3-Loaded Nanostructured Lipid Carriers as a Potential Approach for Fortifying Food Beverages; in Vitro and in Vivo Evaluation

1 December 2017 in Food Bioscience
Verified
Journal Article
Closed access
SBSevda Bagherpour
Sevda Bagherpour
AAAinaz Alizadeh
Ainaz Alizadeh
SGSaeed Ghanbarzadeh
Saeed Ghanbarzadeh
MMMaryam Mohammadi
Maryam Mohammadi
HHHamed Hamishehkar
Hamed Hamishehkar

18 July 2017 in Nutrition and Cancer
Verified
Journal Article
Closed access
MSMehdi Sabzichi
Mehdi Sabzichi
JMJamal Mohammadian
Jamal Mohammadian
MMMaryam Mohammadi
Maryam Mohammadi
FJFarhad Jahanfar
Farhad Jahanfar
APAli Akbar Movassagh Pour
Ali Akbar Movassagh Pour
AOAlireza Ostad-Rahimi
Alireza Ostad-Rahimi
The dangerous dose-dependent side effects of anticancer agents triggered the finding of new approaches for elevated chemotherapy efficacy. This study investigated the potential application of nanostructured lipid careers (NLCs) in increasing vitamin D3 (VitD) effectiveness in breast cancer cell (MCF-7) in concurrent administration with doxorubicin (Dox). VitD-loaded NLCs were characterized by particle size, zeta potential, Fourier transform infrared spectroscopy, and scanning electron microscope. Cytotoxicity and molecular effects of formulation were evaluated by MTT, DAPI staining, flow cytometry, and real-time quantitative PCR assays. The formulation revealed mean particle size of 87±5 nm with a polydispersity index of 0.24 confirmed by SEM images. The IC50 values for VitD and Dox were 1.3 ± 0.04 and 0.65 ± 0.05 µM, respectively. VitD-loaded NLCs decreased the percentage of cell proliferation from 49 ± 7.2% to 37 ± 5.1% (P < 0.05). Cotreatment of the cells with VitD-loaded NLCs and Dox caused over a twofold increase in the percentage of apoptosis (P < 0.05). Gene expression profile demonstrated a significant decrease in antiapoptotic factor survivin along with increase in proapoptotic factor Bax mRNA levels. Overall, our results introduced the NLC technology as a novel strategy to elevate the efficacy of chemotherapeutics in breast cancer.

31 December 2014
Verified
Journal Article
Open access
APAkram Pezeshki
Akram Pezeshki
BGBabak Ghanbarzadeh
Babak Ghanbarzadeh
MMMaryam Mohammadi
Maryam Mohammadi
IFIsa Fathollahi
Isa Fathollahi
HHHamed Hamishehkar
Hamed Hamishehkar
Purpose: Nanostructured lipid carrier (NLC) is a useful delivery system with high capacity for bioactive loading, and suitable stability for fortification of foods and beverages. The objective of the present work is to prepare vitamin A palmitate (vitA)-loaded NLC and to investigate surfactant concentration effect on physicochemical properties of prepared formulation.

1 December 2014
Verified
Journal Article
Open access
PDF file
MMMaryam Mohammadi
Maryam Mohammadi
BGBabak Ghanbarzadeh
Babak Ghanbarzadeh
HHHamed Hamishehkar
Hamed Hamishehkar
Purpose: Vitamin D, a liposoluble vitamin has many benefits on health. Encapsulation of bioactives in lipid-based carrier systems like nanoliposomes preserves their native properties against oxidation over time along with providing its stable aqueous dispersion. Methods: In the current study, vitamin D3 nanoliposomes were prepared using thin-film hydration­- sonication method and fully characterized by different instrumental techniques. Results: According to FTIR and DSC results, no interaction was observed between encapsulated nutraceutical and liposome constituents. The particle size and size distribution (Span value) were calculated 82–90 nm and 0.70–0.85, respectively. TEM analysis showed nano sized globular and bilayer vesicles. In all formations, the encapsulation efficiency of vitamin D3 was calculated more than 93%.­ Addition of cholesterol to lecithin bilayer increased the negative zeta potential from -29 to -43mV. Conclusion: The results of this study concluded that the liposomal nanoparticles may be introduced as a suitable carrier for fortification of beverages with vitamin D3.

1 October 2021 in ASSAY and Drug Development Technologies
Verified
Journal Article
Closed access
PHParviz Hassanpour
Parviz Hassanpour
HHHamed Hamishehkar
Hamed Hamishehkar
BBBehnaz Bahari Baroughi
Behnaz Bahari Baroughi
Behzad BaradaranBehzad Baradaran
Behzad Baradaran
SSSiamak Sandoghchian Shotorbani
Siamak Sandoghchian Shotorbani
SNSanam Nami
Sanam Nami
This study aimed to assess the effect of voriconazole (VCZ)-loaded nano-liposomes on biological activity and expression of ERG11, CDR1, and CDR2 genes in fluconazole (FCZ)-resistant Candida albicans. In this study, 5 resistant isolates of C. albicans and 3 susceptible clinical isolates to FCZ were scrutinized from 60 patients suspected of candidiasis. The liposomal formulation of VCZ was produced. After that, the minimum biofilm inhibitory concentration (MBIC) testing was performed and the percentage of growth inhibition was determined. Finally, ERG11, CDR1, and CDR2 mRNA levels were amplified by the quantitative reverse transcription PCR (qRT-PCR) instrument. The obtained results unveiled that VCZ-loaded nano-liposome reduction of minimum inhibitory concentration in C. albicans isolates was remarkable. The results of the MBIC in the most optimum inhibitory concentration of VCZ-loaded nano-liposome were determined to be 4.54 and 4.88 μg/mL for susceptible isolate and resistant isolate, respectively. The ERG11 gene expression in FCZ-resistant C. albicans strains in VCZ-treated, liposomal formulation of VCZ-treated, and nontreated specimens stood at 91%, 63%, and 100%, respectively. Expression levels of CDR1 genes in FCZ-resistant C. albicans were shown to be 91%, 88%, and 100%, respectively. Concerning CDR2 genes, this rate varied to 91%, 78%, and 100% in FCZ resistant, respectively. What our study unveiled was that the use of liposomal VCZ formulation could further reduce the expression of azole-resistant genes compared to VCZ itself. In addition, thanks to more efficacious penetration of the liposomal form, the rate of growth inhibition was considerably higher.